Search
for
Sort by
Research 151–180 of 1000+
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Adherence with protocol medication use and mortality from unrelated causes in a prevention trial
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Going Beyond Hair: Seven Simple Actions We Can Take to Help Prevent Major Illness in Our Hair Transplant Patients
- Biomarker-based methods for determining noncompliance in a prevention trial
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Pertinence d’une chimioprévention à partir de l’étude PCPT
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Trailing the Path to Preventive Oncology
- Metformin and Malignant Tumors: Not Over the Hill
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- Gender-Affirming Hormone Therapy for Transgender Females
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Androgens in SARS-CoV-2 Coronavirus Infections
- Structural perspectives on the androgen receptor, the elusive shape-shifter
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Dutasteride
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Androgen receptors and their biology
- Androgen Receptor Ligands: Agonists and Antagonists
- Hormesis and medicine
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Life Sciences Discovery and Technology Highlights
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice